Vol. 4 No. 5S (2010)

Published: 2010-07-30

Editorial

Let's have a look at suboptimal patients in TKI era

Antonella Gozzini

3-7
- PDF

Case report

Treatment with nilotinib after cytogenetic relapse at 12 months in a patient in chronic phase with sub-optimal response to imatinib

Massimo Breccia

9-13
- PDF
Nilotinib efficacy in a patient resistant to imatinib

Luigia Luciano

15-18
- PDF
Use of nilotinib in the diabetic patient

Carmen Tomaselli

19-22
- PDF
Nilotinib therapy after resistance and intolerance to imatinib in CML patient with trisomy of the chromosome 8

Antonella Russo Rossi

23-27
- PDF